Functional graphene derivatives for chemotherapy-based synergistic tumor therapy

Xinyu Cui, Wenlong Cheng, Weili Xu, Wei Mu, Xiaojun Han

Research output: Contribution to journalArticleOtherpeer-review

Abstract

Starting from simplex drug delivery system, the graphene oxide (GO) and reduced GO (rGO) materials have been developed to be "combo" nanoplatforms containing multiple therapeutic modalities, such as the targeted drug delivery, imaging, as well as photothermal therapy (PTT) due to their distinctive physical/chemical and optical properties including excellent biocompatibility, modifiable active groups, ultra-large surface area, and intense photothermal effect. The graphene-based nanoplatforms were used for the stimuli-responsive nanocarriers, showing excellent therapeutic effects activated by endogenous stimuli including low pH, overexpressed enzymes, biomolecules, elevated glutathione, and exogenous stimuli including light, magnetic/electric field, and ultrasound. More importantly, for multimodal synergistic therapy originated from the enhanced collaborative interactions among several monotherapy types, the obtained remarkable super-additive effects were not the results just through single therapy or their theoretical combination. In this review, the recent progresses of smart graphene-based nanoplatforms for integrated cancer therapy and bio-imaging are presented. Current challenges and future perspectives of graphene-based nanoplatforms in the biomedical field are also discussed.

Original languageEnglish
Article number1930006
Number of pages19
JournalNano
Volume14
Issue number11
DOIs
Publication statusPublished - Nov 2019

Keywords

  • drug delivery
  • Graphene-based nanomaterials
  • synergistic therapy
  • theranostics

Cite this

Cui, Xinyu ; Cheng, Wenlong ; Xu, Weili ; Mu, Wei ; Han, Xiaojun. / Functional graphene derivatives for chemotherapy-based synergistic tumor therapy. In: Nano. 2019 ; Vol. 14, No. 11.
@article{df04f589fe334a51969a110a902c0995,
title = "Functional graphene derivatives for chemotherapy-based synergistic tumor therapy",
abstract = "Starting from simplex drug delivery system, the graphene oxide (GO) and reduced GO (rGO) materials have been developed to be {"}combo{"} nanoplatforms containing multiple therapeutic modalities, such as the targeted drug delivery, imaging, as well as photothermal therapy (PTT) due to their distinctive physical/chemical and optical properties including excellent biocompatibility, modifiable active groups, ultra-large surface area, and intense photothermal effect. The graphene-based nanoplatforms were used for the stimuli-responsive nanocarriers, showing excellent therapeutic effects activated by endogenous stimuli including low pH, overexpressed enzymes, biomolecules, elevated glutathione, and exogenous stimuli including light, magnetic/electric field, and ultrasound. More importantly, for multimodal synergistic therapy originated from the enhanced collaborative interactions among several monotherapy types, the obtained remarkable super-additive effects were not the results just through single therapy or their theoretical combination. In this review, the recent progresses of smart graphene-based nanoplatforms for integrated cancer therapy and bio-imaging are presented. Current challenges and future perspectives of graphene-based nanoplatforms in the biomedical field are also discussed.",
keywords = "drug delivery, Graphene-based nanomaterials, synergistic therapy, theranostics",
author = "Xinyu Cui and Wenlong Cheng and Weili Xu and Wei Mu and Xiaojun Han",
year = "2019",
month = "11",
doi = "10.1142/S1793292019300068",
language = "English",
volume = "14",
journal = "Nano",
issn = "1793-2920",
publisher = "World Scientific Publishing",
number = "11",

}

Functional graphene derivatives for chemotherapy-based synergistic tumor therapy. / Cui, Xinyu; Cheng, Wenlong; Xu, Weili; Mu, Wei; Han, Xiaojun.

In: Nano, Vol. 14, No. 11, 1930006, 11.2019.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Functional graphene derivatives for chemotherapy-based synergistic tumor therapy

AU - Cui, Xinyu

AU - Cheng, Wenlong

AU - Xu, Weili

AU - Mu, Wei

AU - Han, Xiaojun

PY - 2019/11

Y1 - 2019/11

N2 - Starting from simplex drug delivery system, the graphene oxide (GO) and reduced GO (rGO) materials have been developed to be "combo" nanoplatforms containing multiple therapeutic modalities, such as the targeted drug delivery, imaging, as well as photothermal therapy (PTT) due to their distinctive physical/chemical and optical properties including excellent biocompatibility, modifiable active groups, ultra-large surface area, and intense photothermal effect. The graphene-based nanoplatforms were used for the stimuli-responsive nanocarriers, showing excellent therapeutic effects activated by endogenous stimuli including low pH, overexpressed enzymes, biomolecules, elevated glutathione, and exogenous stimuli including light, magnetic/electric field, and ultrasound. More importantly, for multimodal synergistic therapy originated from the enhanced collaborative interactions among several monotherapy types, the obtained remarkable super-additive effects were not the results just through single therapy or their theoretical combination. In this review, the recent progresses of smart graphene-based nanoplatforms for integrated cancer therapy and bio-imaging are presented. Current challenges and future perspectives of graphene-based nanoplatforms in the biomedical field are also discussed.

AB - Starting from simplex drug delivery system, the graphene oxide (GO) and reduced GO (rGO) materials have been developed to be "combo" nanoplatforms containing multiple therapeutic modalities, such as the targeted drug delivery, imaging, as well as photothermal therapy (PTT) due to their distinctive physical/chemical and optical properties including excellent biocompatibility, modifiable active groups, ultra-large surface area, and intense photothermal effect. The graphene-based nanoplatforms were used for the stimuli-responsive nanocarriers, showing excellent therapeutic effects activated by endogenous stimuli including low pH, overexpressed enzymes, biomolecules, elevated glutathione, and exogenous stimuli including light, magnetic/electric field, and ultrasound. More importantly, for multimodal synergistic therapy originated from the enhanced collaborative interactions among several monotherapy types, the obtained remarkable super-additive effects were not the results just through single therapy or their theoretical combination. In this review, the recent progresses of smart graphene-based nanoplatforms for integrated cancer therapy and bio-imaging are presented. Current challenges and future perspectives of graphene-based nanoplatforms in the biomedical field are also discussed.

KW - drug delivery

KW - Graphene-based nanomaterials

KW - synergistic therapy

KW - theranostics

UR - http://www.scopus.com/inward/record.url?scp=85075522173&partnerID=8YFLogxK

U2 - 10.1142/S1793292019300068

DO - 10.1142/S1793292019300068

M3 - Article

VL - 14

JO - Nano

JF - Nano

SN - 1793-2920

IS - 11

M1 - 1930006

ER -